GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JETEMA Co Ltd (XKRX:216080) » Definitions » Research & Development

JETEMA Co (XKRX:216080) Research & Development : ₩11,026 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is JETEMA Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. JETEMA Co's Research & Development for the three months ended in Mar. 2024 was ₩2,554 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₩11,026 Mil.

JETEMA Co Research & Development Historical Data

The historical data trend for JETEMA Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JETEMA Co Research & Development Chart

JETEMA Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 7,802.85 5,052.42 3,910.09 6,262.54 10,222.50

JETEMA Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,750.86 2,103.30 2,580.60 3,787.74 2,554.38

JETEMA Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩11,026 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JETEMA Co  (XKRX:216080) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

JETEMA Co Research & Development Related Terms

Thank you for viewing the detailed overview of JETEMA Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

JETEMA Co (XKRX:216080) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JETEMA Co Ltd (XKRX:216080) » Definitions » Research & Development
Comparable Companies
XKRX:228760 XKRX:095700 XKRX:334970 XKRX:199800 XKRX:323990 XKRX:115450 XKRX:005690 XKRX:060590 XKRX:358570 XKRX:011000 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
1283-4, Gagok-ri, Jijeong-myeon, Gangwon-do, Wonju, KOR
Website
http://www.jetema.com
JETEMA Co Ltd is a bio venture company. It offers products such as Botulinum toxin, Filler, Anti-aging solutions. The company also offers medical devices and cosmetics.

JETEMA Co (XKRX:216080) Headlines

No Headlines